The IGF-I/IGF-IR Signaling System and Pancreatic Cancer


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Ductal adenocarcinoma is one of the most common and severely aggressive forms of pancreatic cancer. IGF-I is one of the factors that ensures survival and proliferation of tumor cells, and its increased concentration inside the tumor is a characteristic sign of many malignant formations. The goal of this minireview is to provide an up-to-date insight on the roles of the IGF-I/IGF-IR signaling pathway in carcinogenesis and potential opportunities for pharmacologic targeting of IGF-I/IGF-IR in pancreatic tumors.

Авторлар туралы

E. Kopantzev

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Хат алмасуға жауапты Автор.
Email: kopantzev@ibch.ru
Ресей, Moscow, 117997

E. Grankina

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: kopantzev@ibch.ru
Ресей, Moscow, 117997

M. Kopantseva

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: kopantzev@ibch.ru
Ресей, Moscow, 117997

E. Sverdlov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: kopantzev@ibch.ru
Ресей, Moscow, 117997

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Allerton Press, Inc., 2017